Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Integra LifeSciences Holdings Corp issues FY 2014 guidance in line with analysts' estimates


Tuesday, 25 Feb 2014 06:00am EST 

Integra LifeSciences Holdings Corp:Expects FY 2014 revenue to be between $920 mln and $940 mln.Expects FY 2014 GAAP EPS to be between $1.46-$1.64.Expects FY 2014 adjusted EPS to be between $3.00-$3.18.FY 2014 revenue of $932 mln and EPS of $3.13 - Thomson Reuters I/B/E/S. 

Company Quote